SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Teva Pharmaceutical Industries Limited Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40